Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and hexamethonium

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with hexamethonium in 1 studies

Compound Research Comparison

Studies
(3-(2,4-dimethoxybenzylidene)anabaseine)
Trials
(3-(2,4-dimethoxybenzylidene)anabaseine)
Recent Studies (post-2010)
(3-(2,4-dimethoxybenzylidene)anabaseine)
Studies
(hexamethonium)
Trials
(hexamethonium)
Recent Studies (post-2010) (hexamethonium)
1668812,2873129

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaike, A; Kihara, T; Kimura, J; Kochiyama, H; Kume, T; Maeda, T; Sawada, H; Shimohama, S1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and hexamethonium

ArticleYear
Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
    Annals of neurology, 1997, Volume: 42, Issue:2

    Topics: Amyloid beta-Peptides; Animals; Benzylidene Compounds; Bungarotoxins; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Fetus; Hexamethonium; Mecamylamine; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Pyridines; Rats; Receptors, Nicotinic

1997